Jenkin D, Wright D, Folegatti PM, Platt A, et al. Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trial. Lancet Infect Dis 2023 Apr 12:S1473-3099(23)00068.
PMID: 37060917